Opinion

Video

Genetic Screening for IgAN

Key Takeaways

  • Familial IgA nephropathy constitutes up to 15% of cases, prompting consideration of family member screening.
  • No consensus exists on routine screening, but monitoring first-degree relatives may be advisable.
SHOW MORE

Panelists discuss the importance of screening and monitoring family members of individuals with IgA nephropathy, noting that up to 15% of cases are familial and outlining recommendations for the frequency of such assessments.

  1. Up to 15% of IgA nephropathy (IgAN) cases are considered familial, should. Should family members of individuals with IgAN be screened or monitored for signs of the disease? If yes, how often?
Related Videos
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.